However, paliperidone, a DRD2 antagonist, is reported to inhibit GBM growth and decrease the expression of programmed death-ligand 1(PD-L1) in GBM (203), suggesting different roles of DRD2 in different types of cancer. This evidence concerns the gene DRD2 and glioblastoma.